Slide deck: COVID-19 – Epidemiology in Canada (April 7, 2020)
April 7, 2020…Summary of epidemiology, testing and mortality rate; Canada and world statistics. Download COVID-19 slide deck…
Results for: C-THR81-2405 PDF Questions with A Guaranteed Success 2024 ⚒ Easily obtain free download of “ C-THR81-2405 ” by searching on ⏩ www.pdfvce.com ⏪ 🤛Exam C-THR81-2405 Format
MS treatment recommendations during COVID-19 pandemic
March 30, 2020…after the pandemic recedes. Click here to access the Canadian Network recommendations: https://cnmsc.ca/Announcements Click here to access the ABN recommendations: https://cdn.ymaws.com/www.theabn.org/resource/collection/6750BAE6-4CBC-4DDB-A684-116E03BFE634/ABN_Guidance_on_DMTs_for_MS_and_COVID19_APPROVED_11_March.pdf…
Slide deck: COVID-19 – Epidemiology in Canada (March 30, 2020)
March 30, 2020…Summary of epidemiology, testing and mortality rate; Canada and world statistics. Download COVID-19 slide deck…
MS 2020 – the view from a decade ago
March 18, 2020…g support for the idea of MS as an autoimmune disorder. However, practical questions – Why is MS more common in females? What determines the phenotype? – have remained unanswered. Genetics has provided little guidance for prognosis or treatment selection. 4. “The quest for biomarkers as surrogates that would contribute to accurate forecasting of individual prognosis is a vigorous area of investigation… I suspect that this holy grail will remain el…
Evaluating acute migraine therapies: ICER
March 11, 2020…ive. Subsequent discussions set a price-benefit benchmark of up to $3200/year for lasmiditan and $4600/year for ubrogepant – about 10-30% lower than current list prices. Click here for a free download of the ICER report: https://icer-review.org/wp-content/uploads/2019/06/ICER_Acute-Migraine_Evidence_Report_011020_updated_011320.pdf….